![Grey-Header-600x315r](http://osteoremedies.wpengine.com/wp-content/uploads/2019/04/Grey-Header-600x315r-1-300x158.jpg)
G E N T A M I C I N + V A N C O M Y C I N
![Plan-Section-600x1317r](http://osteoremedies.wpengine.com/wp-content/uploads/2019/04/Plan-Section-600x1317r.jpg)
![Asset-2-1024×506](https://osteoremedies.com/wp-content/uploads/2019/05/Asset-2-1024x506.png)
![Proven-Clinically-Effective-1200x509r](http://osteoremedies.wpengine.com/wp-content/uploads/2019/04/Proven-Clinically-Effective-1200x509r-1.jpg)
![hipsection](https://osteoremedies.com/wp-content/uploads/2021/04/hipsection.jpg)
1 Watanakunakom, et al., 1980 Journal of Antimicrobial Chemotherapy 6, 785-791.
2 Watanakunakom, et al., 1982 Antimicrobial Agents and Chemotherapy 903-905.
3 Minelli, E. Bertazzoni, et al., 2011. Anaerobe 17(6), 380-383.
4 Trampuz, A., et. al., 2005. Swiss Med Weekly. 135(17-18): 243-51. Review.
5 For complete data and associated risks reference the REMEDY SPECTRUM® GV Hip IFU. In a review of 22 patients, clinical effectiveness was defined as the absence of 2 or more positive cultures at the time of reimplanation. Patients should be monitored for ototoxicity and nephrotoxicity while under-going treatment for PJI.